AtriCure Inc
NASDAQ:ATRC
Relative Value
The Relative Value of one
ATRC
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 29.175 USD,
AtriCure Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
ATRC Competitors Multiples
AtriCure Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
AtriCure Inc
NASDAQ:ATRC
|
1.5B USD | 2.7 | -126.9 | 122.3 | -143.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.1B USD | 4.1 | 28.1 | 16.1 | 22.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
169.7B USD | 16.9 | 59.4 | 45.1 | 55.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
128.4B USD | 5.1 | 39.6 | 20.2 | 24.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.6B USD | 3.1 | 24 | 13.3 | 19.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103B USD | 5.1 | 35.6 | 20.9 | 28.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD | 7.9 | 44.7 | 24.6 | 26.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.6 | 11 | 15.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46B USD | 10.7 | 43.4 | 30.8 | 34.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
43.9B USD | 2 | 25 | 9.9 | 16.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD | 6.1 | 22.2 | 15.6 | 17.3 |